Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-58037
Mikhailidis, D P; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, A; Athyros, V; de Graaf, J; März, W; Parhofer, K G; Rini, G B; Spinas, G A; Tomkin, G H; Tselepis, A D; Wierzbicki, A S; Winkler, K; Florentin, M; Liberopoulos, E (2011). "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Current Vascular Pharmacology, 9(5):533-571.
PDF - Registered users only
Aim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density liproproteins (LDL) subclasses. We sub-divided our statement in 2 sections. section I discusses the pathophysiology, atherogenicity and measurement issues, while section II is focused on the effects of drug and lifestyle modifications. Suggestions for future research in the field are highlighted at the end of section II. Each section includes Conclusions.
1 download since deposited on 03 Feb 2012
0 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Endocrinology and Diabetology|
|DDC:||610 Medicine & health|
|Deposited On:||03 Feb 2012 08:59|
|Last Modified:||07 Feb 2014 04:12|
|Publisher:||Bentham Science Publishers|
|ISSN:||1570-1611 (P) 1875-6212 (E)|
|Related URLs:||http://benthamscience.com/cvp/ (Publisher)|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page